Agony and ecstasy: a review of MDMA effects and toxicity

被引:63
作者
Burgess, C [1 ]
O'Donohoe, A [1 ]
Gill, M [1 ]
机构
[1] St James Hosp, Trinity Hlth Sci Ctr, Dept Psychiat, Dublin 8, Ireland
关键词
ecstasy; genetic; MDMA; serotonin; toxicity;
D O I
10.1016/S0924-9338(00)00396-5
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background - Ecstasy is a recreational drug with an anecdotal reputation for safety. However, reports of adverse effects and fatalities have increased in the medical and popular press. Method - Literature search and review. Results - Acute Ecstasy toxicity does not appear to be due to overdose and cannot be solely attributed to the nature of the usual ambient environment. Adverse effects include hyperthermia, seizures, cardiac arrhythmias, hepatotoxicity, hyponatraemia and many psychiatric disorders. Ecstasy causes serotonergic neurotoxicity in the brains of animals at doses close to those used by humans, but its long-term effect on the human brain is unknown. Conclusion - Ecstasy toxicity should be considered in the differential diagnosis of a variety of medical and psychiatric conditions. Given its popularity, both the acute and the potential long-term effects are a cause for concern. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:287 / 294
页数:8
相关论文
共 62 条
[1]   PERSISTENT EFFECTS OF (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY) ON HUMAN SLEEP [J].
ALLEN, RP ;
MCCANN, UD ;
RICAURTE, GA .
SLEEP, 1993, 16 (06) :560-564
[2]   RECENT DEVELOPMENTS IN HEPATIC DRUG OXIDATION - IMPLICATIONS FOR CLINICAL PHARMACOKINETICS [J].
BROSEN, K .
CLINICAL PHARMACOKINETICS, 1990, 18 (03) :220-239
[3]   MULTIPLE SEVERE COMPLICATIONS FROM RECREATIONAL INGESTION OF MDMA (ECSTASY) [J].
BROWN, C ;
OSTERLOH, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (06) :780-781
[4]   Use of drugs at 'raves' [J].
Brown, ERS ;
Jarvie, DR ;
Simpson, D .
SCOTTISH MEDICAL JOURNAL, 1995, 40 (06) :168-171
[5]   In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine [J].
Colado, MI ;
OShea, E ;
Granados, R ;
Murray, TK ;
Green, AR .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (05) :889-900
[6]   THE HYPERTHERMIC AND NEUROTOXIC EFFECTS OF ECSTASY (MDMA) AND 3,4-METHYLENEDIOXYAMPHETAMINE (MDA) IN THE DARK-AGOUTI (DA) RAT, A MODEL OF THE CYP2D6 POOR METABOLIZER PHENOTYPE [J].
COLADO, MI ;
WILLIAMS, JL ;
GREEN, AR .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (07) :1281-1289
[7]  
Concar D, 1997, NEW SCI, V155, P20
[8]   Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): Week-end 'high' followed by mid-week low [J].
Curran, HV ;
Travill, RA .
ADDICTION, 1997, 92 (07) :821-831
[9]  
de la Torre R, 1999, LANCET, V353, P593, DOI 10.1016/S0140-6736(05)75653-1
[10]   EVE AND ECSTASY - A REPORT OF 5 DEATHS ASSOCIATED WITH THE USE OF MDEA AND MDMA [J].
DOWLING, GP ;
MCDONOUGH, ET ;
BOST, RO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (12) :1615-1617